Literature DB >> 16696091

Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude mice.

K Sandvej1, M Munch, S Hamilton-Dutoit.   

Abstract

Aims-(1) To study the frequency of putative malignancy associated point mutations and a 30 base pair (bp) deletion in exon 3 of the C-terminus of the Epstein-Barr virus (EBV) encoded latent membrane protein (LMP)-1 (BNLF-1) gene in wild type EBV strains. (2) To assess the influence of these mutations on the tumorigenicity of lymphoblastoid cell lines (LCL).Methods-Eight spontaneous EBV (wild type) infected LCL were established from seven subjects. Deletions and single base mutations in the C-terminus of the BNLF-1 gene were demonstrated using bi-directional solid phase dideoxy sequencing following PCR amplification of viral DNA from the LCL. Tumorigenicity of the LCL was assessed in SCID and nude mice. Serum dependent growth and ability to form colonies in soft agarose were assessed for representative LCL.Results-All LCL showed sequence differences compared with the prototypic EBV strain B95-8. The 30 bp deletion could be detected in three of eight LCL and a 69 bp deletion (including the 30 bp deletion) was identified in an additional LCL. A range of single base mutations (including those described previously in association with EBV related neoplasias) was also seen in some of the LCL. In transformation studies, the genetic variations did not seem to influence the in vitro behaviour of the LCL. In the tumorigenicity studies, the presence of the 30 bp deletion had no influence on the behaviour of the LCL which were, as expected, tumorigenic in SCID mice but not in nude mice. In contrast, the LCL carrying the 69 bp deletion was tumorigenic in both SCID and nude mice.Conclusions-Genetic changes described previously in the C-terminus of the LMP-1 gene in various malignancy derived EBV strains are also present frequently in wild type viruses and do not simply define tumour specific EBV strains. Changes within this region may, however, still be important for the tumorigenicity of LMP-1 and thus play a role in EBV oncogenesis.

Entities:  

Year:  1996        PMID: 16696091      PMCID: PMC408075          DOI: 10.1136/mp.49.5.m290

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  37 in total

1.  Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.

Authors:  S N Li; Y S Chang; S T Liu
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

2.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

Authors:  G Henle; W Henle; V Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

3.  The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

Authors:  D S Huen; S A Henderson; D Croom-Carter; M Rowe
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

4.  Sequence variation in the Epstein-Barr virus latent membrane protein 1.

Authors:  W E Miller; R H Edwards; D M Walling; N Raab-Traub
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

5.  PCR typing of DNA fragments of the short tandem repeat (STR) system HUMTH01 in Danes and Greenland Eskimos.

Authors:  L J Nellemann; A Møller; N Morling
Journal:  Forensic Sci Int       Date:  1994-09-06       Impact factor: 2.395

6.  Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.

Authors:  K Sandvej; S C Peh; B S Andresen; G Pallesen
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

7.  Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.

Authors:  J Sample; E F Kieff; E D Kieff
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

8.  All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

Authors:  R K Moorthy; D A Thorley-Lawson
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

Authors:  P Trivedi; L F Hu; F Chen; B Christensson; M G Masucci; G Klein; G Winberg
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.

Authors:  M Rowe; M Peng-Pilon; D S Huen; R Hardy; D Croom-Carter; E Lundgren; A B Rickinson
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  4 in total

1.  Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders.

Authors:  M Rowe; G Niedobitek; L S Young
Journal:  Springer Semin Immunopathol       Date:  1998

2.  The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.

Authors:  K M Izumi; E D Cahir McFarland; E A Riley; D Rizzo; Y Chen; E Kieff
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.

Authors:  R J Johnson; M Stack; S A Hazlewood; M Jones; C G Blackmore; L F Hu; M Rowe
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line.

Authors:  Charlotte Sueur; Julien Lupo; Philippe Mas; Patrice Morand; Véronique Boyer
Journal:  Virol J       Date:  2014-05-19       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.